Key Takeaways
- Adding a genetic counselor to cancer tumor board discussions nearly quadrupled how often inherited genetic testing was recommended – from 10% to 37%
- Genetic counselors identified cancer patients who might benefit from testing based on more than their tumor test results, including their personal medical history
- Germline testing can uncover inherited cancer risk that may help guide treatment and screening, as well as provide important information for family members
- Findings presented this week at the National Society of Genetic Counselors (NSGC) 45th Annual Conference
BALTIMORE – Nov. 12, 2026 – Cancer patients were nearly four times as likely to be referred for germline genetic testing when a genetic counselor participated in cancer tumor board discussions about their case, according to new research presented at the National Society of Genetic Counselors (NSGC) 45th Annual Conference. Germline testing can provide information that may help guide cancer treatment decisions and identify a patient’s risk for other cancers.
Germline testing looks for inherited genetic changes a person was born with that may increase their risk of cancer — and potentially signal increased risk for family members. It differs from tumor testing, which looks for genetic changes in the cancer itself to help guide treatment. Genetic counselors consider tumor testing results, along with a patient’s personal and family history and genetic-testing guidelines, to determine who may benefit from germline testing.
“Genetic counselors bring a broader understanding of the patient as well as in-depth knowledge about genetic-testing guidelines to the discussion, helping to identify substantially more people who might benefit from germline genetic testing,” said Lauren Velez, MS, CGC, lead author and a cancer genetic counselor at Munson Healthcare, Traverse City, Michigan.
For example, in someone with breast cancer, finding an inherited BRCA1 mutation through germline testing could open the door to a targeted treatment such as a PARP inhibitor. It also may reveal an additional increased risk for other cancers, such as ovarian or pancreatic cancer, so patients can make sure they receive appropriate screening.
The researchers reviewed 524 patient cases discussed at Maine Cancer Genomic Initiative tumor boards from June 2019 to June 2023, including two years before and two years after a genetic counselor was added to the meetings. Germline testing was recommended in 83 of 227 cases (36.5%) discussed with a genetic counselor present, compared with 29 of 297 cases (9.8%) discussed without one, a statistically significant difference.
The reasons for recommending testing also shifted. Without a genetic counselor, nearly three-quarters (72.4%) of recommendations were prompted by findings from the patient's tumor testing. When a genetic counselor participated, personal medical history became the most common reason for recommending germline testing, accounting for nearly two-thirds (63.9%) of recommendations. Personal history such as developing cancer at an unusually young age, can provide important clues that a patient may have an inherited cancer risk.
Genetic counselors are trained to recognize when a patient's personal or family history may warrant germline testing and to stay current on genetic-testing guidelines, Velez said. After a genetic counselor joined the tumor boards, a formal germline assessment became part of the discussion for every patient, helping identify those who met testing guidelines or whose medical or family history suggested further germline testing may be appropriate.
“For example, when three or more relatives on one side of the patient’s family have had breast or prostate cancer, a genetic counselor may recommend testing for the patient or their relatives to determine whether an inherited variant in a gene such as BRCA1 could be contributing to the family’s cancer risk,” said Velez. “Or a patient diagnosed with colon cancer at age 36 may be referred for germline testing because developing the disease at such a young age can be a sign of inherited cancer risk.”
“Genetic counselors are essential healthcare partners for patients, their families and the teams caring for them as they face cancer diagnosis and treatment," said Carrie Haverty, MS, CGC, president of the National Society of Genetic Counselors. “This research shows real-world evidence of the value of genetic counselors in navigating the complex interplay between cancer and genetics.”
News releases may contain updated data or language that does not match what is reported in the abstract.
# # #
Note to editors: Media interested in viewing study abstracts, interviewing authors and/or attending sessions at the NSGC Annual Conference can contact NSGC’s PR team at NSGCPR@pcipr.com.
About the National Society of Genetic Counselors
NSGC is the leading voice, authority and advocate for the genetic counseling profession. Membership represents more than 5,000 masters-level health professionals, who are committed to ensuring that the public has access to genetic counseling and genetic testing. For more information, visit www.nsgc.org.
# # #